Manila Times Business
Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries
CHICAGO, June 10, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly-owned subsidiary, Cana Laboratories ("Cana"), has secured a three-year contract manufacturing agreement with Verisfield S.A. ("Verisfield”), a specialty pharmaceutical company focused on the development and marketing of generic and differentiated pharmaceutical products across multiple therape
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Debut Novel by Susan Price Brings 1970s Newport to Life in Summer Read
2h ago
West Red Lake Gold Announces Results of Annual General Meeting
2h ago
Fennec Announces Results of Annual Meeting
2h ago
Credit Acceptance Announces Appointment of Joe Billante as Chief Financial Officer; Jay Martin to Retire After More Than Two Decades of Service
2h ago